Navigation Links
Russia's International Biotechnology Center Generium Signs Access Agreement to Elsevier's ScienceDirect and Embase
Date:10/31/2013

MOSCOW, October 31, 2013 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that Russia's International Biotechnology Center (IBC) Generium, has signed an agreement to grant access to ScienceDirect and Embase for its scientists.

Access to ScienceDirect, Elsevier's full-text platform for scientific, technical and medical research literature and Embase, the most comprehensive international database for biomedical researchers, supports the company's strategy to maintain its leading position in Russia in generic drug development and innovate in biotechnological therapies.

Established in 2011, Generium has a unique and extensive portfolio of innovative drugs and biotechnological therapies. Generium's aim is to innovate in biotechnological therapies against diseases such as oncology as well as cardio-vascular, neurodegenerative and autoimmune disorders. The center's research and development teams will benefit greatly from its newly acquired access to ScienceDirect and Embase, by providing them with peer-reviewed full-text research papers published in more than 2000 international journals, as well as timely access to biomedical information.

Dr. Andrei Petrov, Chief Scientific Officer of Generium, said, "We are delighted to reach this agreement with Elsevier providing our research and development teams with online access to an extensive stream of world-class scientific content which will substantially facilitate our own research on drug discovery and development. We consider both ScienceDirect and Embase as critical tools for strengthening our competitive position."

Igor Osipov'/>"/>

SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. UV Flu Technologies Expands Its International Footprint
2. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
3. International Attendance for Networking and Education at Informex Beyond Manufacturing
4. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
5. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
6. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
7. PAREXEL International to Present at J.P. Morgan Healthcare Conference
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
10. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
11. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/30/2015)... ... July 30, 2015 , ... As part of its 2015 growth plan and as ... technical service business units, Whitehouse Laboratories is pleased to announce that it has ... the Container Center of Excellence and will be strictly dedicated to basic USP 51, USP ...
(Date:7/29/2015)... 30, 2015 Sanofi, un ... ses résultats pour le premier semestre 2015. Le ... résultats. Visionner l,interview vidéo et lire ... Au sommaire de l,interview :  ... de croissance - Diabète ...
(Date:7/29/2015)... (Q2 2015: +14% CER / 20% of sales) led the regional performance ... , as well as solid contributions from Korea, India ... Middle East / Africa (Q2 ... , Turkey and the United Kingdom ... 11%, excluding U.S. HPV sales, on demand across all customer classes. The top ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10
... MS, EDMONTON, Oct. 6 /PRNewswire-FirstCall/ - BioMS ... treatment of multiple sclerosis (MS), today,announced that the ... phase II MINDSET-01 trial of dirucotide (MBP8298) in ... and recommended,that the trial continue as per the ...
... from years of, study by leading research scientists in Russia, ... ... Colo., Oct. 6 On Thursday, October 16, 2008 at,the EUPROBIO 2008 ... on cytotoxicity of,natural killer cells" will be presented to physicians, researchers and,educators. ...
... BOSTON, Oct. 6 PAREXEL International,Corporation (Nasdaq: ... at the,William Blair Small-Cap Growth Stock Conference in ... Chief Financial Officer will be making,a formal presentation ... October 7,2008., A live webcast of this ...
Cached Biology Technology:BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board 2EUPROBIO 2008 Presentation to Highlight Latest Immune Research 2PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference 2
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
(Date:7/13/2015)... Conn. , Jul. 13, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/188684 for ... achieves another new convenient and secure method to ... new, innovative payment methods, introduced with its groundbreaking ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... a world-leading provider of scientific, technical and medical information ... for Parasitology, is pleased to announce the launch of ... and Wildlife . The new electronic open access ... International Journal for Parasitology , and will address ...
... 2012 National data indicate that milk consumption has ... low nutritional quality has more than doubled. Although this ... drinks in children,s diets, a new study suggests that ... significantly related to changes in their consumption of sodas ...
... Western University in London, Canada and the Children,s Health ... Institute, have identified the critical role of a receptor ... beta cells, making it an exciting therapeutic target for ... by Rennian Wang, demonstrated that overexpression of c-Kit not ...
Cached Biology News:Elsevier launches International Journal for Parasitology: Parasites and Wildlife 2Sugar-sweetened drinks are not replacing milk in kid's diets 2Sugar-sweetened drinks are not replacing milk in kid's diets 3A 'Kit' for increasing insulin production 2